SCHEMBL8516909

SCHEMBL8516909

FC(F)(F)c1ccccc1CC(Nc1ncnc2ccccc12)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GALR3 O60755 3/20 0.51
▸ NR2F2 P24468 3/20 0.51
▸ EGFR P00533 7/20 0.43
▸ RAB9A P51151 1/20 0.41
▸ ABCG2 Q9UNQ0 2/20 0.41
▸ DYRK1A Q13627 4/20 0.41
▸ AURKB Q96GD4 2/20 0.41
▸ DAPK3 O43293 1/20 0.41
▸ MAP4K4 O95819 1/20 0.41
▸ ABL1 P00519 1/20 0.41
▸ ERBB2 P04626 1/20 0.41
▸ PIM1 P11309 1/20 0.41
▸ PRKACA P17612 1/20 0.41
▸ LTK P29376 1/20 0.41
▸ MAPK8 P45983 1/20 0.41
▸ CSNK1A1 P48729 1/20 0.41
▸ RPS6KA3 P51812 1/20 0.41
▸ LIMK1 P53667 1/20 0.41
▸ MAP2K1 Q02750 1/20 0.41
▸ ACVR1 Q04771 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8516838 0.83 GALR3 (0.50) GALR3NR2F2EGFRRAB9AABCG2
SCHEMBL8504743 0.80 GALR3 (0.61) GALR3NR2F2EGFRRAB9AABCG2
SCHEMBL9608168 0.79 GALR3 (0.46) GALR3NR2F2EGFRRAB9AABCG2
SCHEMBL9430904 0.76 EGFR (0.68) GALR3NR2F2EGFRRAB9AABCG2
SCHEMBL8516930 0.76 RAB9A (0.46) EGFRRAB9AAURKBLMNASMN1; SMN2
SCHEMBL6121969 0.75 GALR3 (0.58) GALR3NR2F2EGFRRAB9AABCG2
SCHEMBL8495218 0.74 LMNA (0.60) GALR3NR2F2EGFRRAB9AABCG2
SCHEMBL8484019 0.73 GALR3 (0.47) GALR3NR2F2EGFRABCG2CLK4
SCHEMBL8516559 0.72 GALR3 (0.45) GALR3NR2F2EGFRABCG2DYRK1A
SCHEMBL8491653 0.72 EGFR (0.49) GALR3NR2F2EGFRABCG2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120136150-A1 4-(3-Butynyl)Aminopyrimidine Derivatives as Pest Control Agents for Agricultural and Horticultural Use SDS BIOTECH K.K. (JP) 2012-05-31 — — US disclosed
EP-2455371-A1 4-(3-BUTYNYL)AMINOPYRIMIDINE DERIVATIVES AS PEST CONTROL AGENTS FOR AGRICULTURAL AND HORTICULTURAL USE SDS Biotech K. K. (JP) 2012-05-23 — — EP disclosed
WO-2011007839-A1 4-(3-BUTYNYL)AMINOPYRIMIDINE DERIVATIVES AS PEST CONTROL AGENTS FOR AGRICULTURAL AND HORTICULTURAL USE 株式会社エス・ディー・エス バイオテック (JP) 2011-01-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120136150-A1 4-(3-Butynyl)Aminopyrimidine Derivatives as Pest Control Agents for Agricultural and Horticultural Use CBR3, CBR1, HRH2 GALR3 597/4885NR2F2 910/4885EGFR 2442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback